13 Hrs
Source:
أخبار الصين
U.S. Launches Section 301 Probe into Germany
The United States has launched an investigation under Section 301 against Germany to determine whether Germany's reduction of spending on innovative medicines is harming American business interests. This comes after months of dialogue between the two countries, during which Washington urged Germany to correct its stance and agree to the drug pricing agreements made with Britain to promote investment and innovation in the pharmaceutical sector.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)